Life-saving medicines will never go out of style -- just one of the things that make drugmakers excellent potential stocks to buy and hold on to for years. However, not all drugmakers on the market are great stock picks.
Here's one company in this sector that's not worth your hard-earned cash: Teva Pharmaceutical Industries (NYSE: TEVA) . This company faces an uphill battle in a difficult segment of the industry to navigate. In addition, it is currently battling company-specific problems that make it even less attractive.
Data by YCharts .
For further details see:
1 Healthcare Stock to Avoid in 2022